The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET
Abstract
This study examined the effects of L-dopa medication in patients with Parkinson's disease on cortical and subcortical blood flow changes during two tasks known to involve frontostriatal circuitry. Eleven patients with Parkinson's disease were scanned on two occasions, one ON L-dopa medication and one OFF L-dopa medication, during performance of the Tower of London planning task and a related test that emphasized aspects of spatial working memory. L-dopa-induced decreases were observed in the right dorsolateral prefrontal cortex during performance of both the planning and the spatial working memory tasks compared with the visuomotor control task. Conversely, L-dopa-induced blood flow increases were observed in the right occipital lobe during the memory task relative to the control task. Data from age-matched healthy volunteers demonstrated that L-dopa effectively normalized blood flow in these regions in the patient group. Moreover, a significant correlation was found between L-dopa-induced, planning related blood flow decreases in the right dorsolateral prefrontal cortex and L-dopa-induced changes in performance on the planning task. These data suggest that L-dopa ameliorates high-level cognitive deficits in Parkinson's disease by inducing relative blood flow changes in the right dorsolateral prefrontal cortex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Statistical Methods for Psychology.
Gudgeon, A. C., & Howell, D. C. (1994) · The Statistician · doi:10.2307/2348956 · Cited by 8,278
Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058
Specific impairments of planning
Shallice, T. (1982) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1982.0082 · Cited by 3,741
INTERHEMISPHERIC DIFFERENCES IN THE LOCALIZATION OF PSYCHOLOGICAL PROCESSES IN MAN
MILNER, B. (1971) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070866 · Cited by 2,329
The neural correlates of the verbal component of working memory
Paulesu, E., Frith, C. D., & Frackowiak, R. S. J. (1993) · Nature · doi:10.1038/362342a0 · Cited by 2,230 · cited 2×
“Thus, both the Wisconsin Card Sorting Test and various tests of verbal memory that are predominantly associated with left hemisphere activation (Berman and Weinberger, 1990; Paulesu et al., 1993) yield drug-induced effects in the same hemisphere (Daniel et al.”
BackgroundA three-dimensional statistical analysis for CBF activation studies in human brain
Worsley, K. J., Evans, A. C., Marrett, S., & Neelin, P. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.127 · Cited by 2,036
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Cited by
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673
Self-citationCools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903
Self-citationMattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., & Obeso, J. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70293-5 · Cited by 863
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2004) · Brain · doi:10.1093/brain/awh067 · Cited by 688
Self-citationMental fatigue and the control of cognitive processes: effects on perseveration and planning
van der Linden, D., Frese, M., & Meijman, T. F. (2003) · Acta Psychologica · doi:10.1016/s0001-6918(02)00150-6 · Cited by 646
Boggio, P. S., Ferrucci, R., Rigonatti, S. P., Covre, P., Nitsche, M., Pascual-Leone, A., & Fregni, F. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.062 · Cited by 643
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2013) · Neurodegenerative Diseases · doi:10.1159/000341998 · Cited by 573
Self-citationHeterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
Lewis, S. J. G. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.033530 · Cited by 551
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544
“In PD, Ldopa withdrawal impairs cognitive performance on tasks sensitive to frontal lobe dysfunction (Lange et al. 1992) in association with hyperactivation of dlPFC (Cools et al. 2002).”
BackgroundLewis, S. J. G., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06351.2003 · Cited by 532
Self-citationChudasama, Y., Passetti, F., Rhodes, S. E. V., Lopian, D., Desai, A., & Robbins, T. W. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.020 · Cited by 518
Self-citationCognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry
Owen, A. M. (2004) · The Neuroscientist · doi:10.1177/1073858404266776 · Cited by 496
Self-citationZgaljardic, D. J., Borod, J. C., Foldi, N. S., & Mattis, P. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00001 · Cited by 421
Dopaminergic modulation of cortical function in patients with Parkinson's disease
Mattay, V. S., Tessitore, A., Callicott, J. H., Bertolino, A., Goldberg, T. E., Chase, T. N., Hyde, T. M., & Weinberger, D. R. (2002) · Annals of Neurology · doi:10.1002/ana.10078 · Cited by 402
Enhancement of Planning Ability by Transcranial Direct Current Stimulation
Dockery, C. A., Hueckel-Weng, R., Birbaumer, N., & Plewnia, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0065-09.2009 · Cited by 380
Metabolic brain networks associated with cognitive function in Parkinson's disease
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M., & Eidelberg, D. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.003 · Cited by 361
Neural Bases of Set-Shifting Deficits in Parkinson's Disease
Monchi, O., Petrides, M., Doyon, J., Postuma, R. B., Worsley, K., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4860-03.2004 · Cited by 341
Under the curve: Critical issues for elucidating D1 receptor function in working memory
Williams, G. V., & Castner, S. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.028 · Cited by 326
The molecular genetics of cognition: dopamine, COMT and BDNF
Savitz, J., Solms, M., & Ramesar, R. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00163.x · Cited by 320
Lewis, S. J. G., Slabosz, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.10.001 · Cited by 309
Self-citationVisual dysfunction in Parkinson disease without dementia
Uc, E. Y., Rizzo, M., Anderson, S. W., Qian, S., Rodnitzky, R. L., & Dawson, J. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191565.11065.11 · Cited by 308
Dopamine enhances model-based over model-free choice behavior
Wunderlich, K., Smittenaar, P., & Dolan, R. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.042 · Cited by 294
“Dopamine has previously been associated with an enhancement of cognitive functions such as reasoning, rule learning, set shifting, planning, and working memory (Clatworthy et al., 2009; Cools and D’Esposito, 2011; Cools et al., 2002; Lewis et al., 2005; Mehta et al., 2005), and these processes are most likely coopted…”
BackgroundDeficits in saccadic eye-movement control in Parkinson's disease
Chan, F., Armstrong, I. T., Pari, G., Riopelle, R. J., & Munoz, D. P. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.06.026 · Cited by 293
Chemistry of the mind: Neurochemical modulation of prefrontal cortical function
Robbins, T. W. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20717 · Cited by 292
Self-citationL-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease
Cools, R., Lewis, S. J. G., Clark, L., Barker, R. A., & Robbins, T. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301153 · Cited by 289
Self-citationGoschke, T., & Bolte, A. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.07.015 · Cited by 288
van Eimeren, T., Monchi, O., Ballanger, B., & Strafella, A. P. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.97 · Cited by 275
Cognitive deficits and striato-frontal dopamine release in Parkinson's disease
Sawamoto, N., Piccini, P., Hotton, G., Pavese, N., Thielemans, K., & Brooks, D. J. (2008) · Brain · doi:10.1093/brain/awn054 · Cited by 263
Chemistry of the adaptive mind
Cools, R., & Robbins, T. W. (2004) · Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2004.1468 · Cited by 257
Self-citationMehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00221.x · Cited by 259
The role of the basal ganglia in learning and memory: Neuropsychological studies
Grahn, J. A., Parkinson, J. A., & Owen, A. M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.020 · Cited by 255
Self-citationCognitive deficits in Parkinson's disease: A cognitive neuroscience perspective
Robbins, T. W., & Cools, R. (2014) · Movement Disorders · doi:10.1002/mds.25853 · Cited by 235
Self-citationTolcapone improves cognition and cortical information processing in normal human subjects
Apud, J. A., Mattay, V., Chen, J., Kolachana, B. S., Callicott, J. H., Rasetti, R., Alce, G., Iudicello, J. E., Akbar, N., Egan, M. F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301227 · Cited by 242
Age-related changes in midbrain dopaminergic regulation of the human reward system
Dreher, J.-C., Meyer-Lindenberg, A., Kohn, P., & Berman, K. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802127105 · Cited by 230
Barch, D. M., & Carter, C. S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.019 · Cited by 222
Schott, B. H., Seidenbecher, C. I., Fenker, D. B., Lauer, C. J., Bunzeck, N., Bernstein, H.-G., Tischmeyer, W., Gundelfinger, E. D., Heinze, H.-J., & Düzel, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3463-05.2006 · Cited by 214
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease
Niethammer, M., Tang, C. C., LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Sarkar, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90133 · Cited by 124
Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition
Rasetti, R., Mattay, V. S., Stankevich, B., Skjei, K., Blasi, G., Sambataro, F., Arrillaga-Romany, I. C., Goldberg, T. E., Callicott, J. H., Apud, J. A., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.83 · Cited by 83
Usefulness of Screening Tools for Predicting Driving Performance in People With Parkinson’s Disease
Classen, S., Witter, D. P., Lanford, D. N., Okun, M. S., Rodriguez, R. L., Romrell, J., Malaty, I., & Fernandez, H. H. (2011) · American Journal of Occupational Therapy · doi:10.5014/ajot.2011.001073 · Cited by 49
Chao, O. Y.-H., Pum, M. E., & Huston, J. P. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.003 · Cited by 39
Ray, N. J., & Strafella, A. P. (2012) · Movement Disorders · doi:10.1002/mds.25173 · Cited by 35
“Using fMRI, levodopa has been shown to normalize activity in the right DLPFC during tasks requiring planning and working memory.(17) On the other hand, cognitive skills dependent on corticoventral striatal loops, which include the nucleus accumbens, the amygdala, the orbitofrontal cortex (OFC), the anterior cingulate…”
Gruszka, A., Hampshire, A., Barker, R. A., & Owen, A. M. (2017) · Cortex · doi:10.1016/j.cortex.2017.05.020 · Cited by 25
Self-citation
Metadata
- Authors
- Cools, R., Stefanova, E., Barker, R. A., Robbins, T. W., & Owen, A. M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-03-01
- Volume
- 125
- Issue
- 3
- Pages
- 584-594
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2147659195
- Cited by
- 396
- References
- 65
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.